NCT03552315

Brief Summary

It has previously been shown in healthy subjects, that a carbonated water containing a mix of amino acids and chromium picolinate can decrease postprandial blood glucose. Based on these findings, a flavored sparkling water product called Good Idea® with a proprietary blend of five amino acids and chromium picolinate has been developed. This product, along with an identical placebo, are included in this study to evaluate the effects on postprandial blood glucose in healthy, overweight adults when consumed with a standardized, high glycemic test meal. The study will be conducted in a cross-over design, double-blinded and placebo controlled, including 45 participants. The primary endpoint of the study is the incremental area under the curve (iAUC) for capillary blood glucose within 180 minutes after ingestion of the meal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

April 24, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 11, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2018

Completed
Last Updated

September 4, 2019

Status Verified

September 1, 2019

Enrollment Period

4 months

First QC Date

April 23, 2018

Last Update Submit

September 2, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • The three-hour incremental area under the curve (iAUC) for capillary blood glucose, 0-180 minutes

    The incremental area under the curve for capillary blood glucose will be measured within 180 minutes after a test meal. Blood samples will be collected at 8 time points during the 180 minutes.

    0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal

Secondary Outcomes (3)

  • The three-hour iAUC for insulin, 0-180 minutes

    0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal

  • The three hour iAUC for intravenous glucose, 0-180 minutes

    0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal

  • The one-hour iAUC for intravenous Glucagon-like peptide 1 (GLP-1), 0-60 minutes

    0, 15, 30, 45 and 60 minutes post test meal

Other Outcomes (6)

  • The three-hour Cmax of capillary blood glucose, venous blood glucose and venous blood insulin

    0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal

  • The Tmax (time to maximum concentration) of capillary blood glucose, venous blood glucose and venous blood insulin

    0, 15, 30, 45, 60, 90, 120 and 180 minutes post test meal

  • The two-hour iAUC for capillary blood glucose, venous blood glucose and venous blood insulin

    0, 15, 30, 45, 60, 90 and 120 minutes post test meal

  • +3 more other outcomes

Study Arms (2)

Water with amino acids and chromium

ACTIVE COMPARATOR

The carbonated water with a proprietary blend of five amino acids and chromium picolinate is consumed with a standardized test meal to study its effects on glucose and insulin responses.

Dietary Supplement: Carbonated water with amino acids and chromium

Carbonated water

PLACEBO COMPARATOR

The placebo carbonated water is consumed with a standardized test meal to study its effects on glucose and insulin responses.

Dietary Supplement: Placebo Carbonated Water

Interventions

The active carbonated water containing amino acids and chromium picolinate is consumed with a standardized test meal. Postprandial glucose and insulin response is documented for 180 minutes

Water with amino acids and chromium
Placebo Carbonated WaterDIETARY_SUPPLEMENT

The placebo carbonated water is consumed with a standardized test meal. Postprandial glucose and insulin response is documented for 180 minutes

Carbonated water

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female 18 to 50 years of age
  • BMI 25-29.9 (±0.5) kg/m²
  • Agree to maintain consistent dietary habits and physical activity levels for the duration of the study
  • Healthy as determined by medical history and information provided by the volunteer
  • Willingness to complete questionnaires and follow instructions associated with the study and to complete all visits
  • Has given voluntary, written, informed consent to participate in the study

You may not qualify if:

  • Elevated fasting blood glucose (at or above 6.1 mmol/L)
  • Women who are pregnant or breast feeding
  • Any medical condition(s) or medication(s) known to significantly affect glucose metabolism. Significance to be assessed by the QI
  • Use of medication, over-the-counter medication, natural health products or dietary supplements/probiotics that may affect glucose metabolism is prohibited during this study. Significance to be assessed by the qualified investigator (QI). Participants who are taking allowed prescribed medications must agree to maintain their current method and dosing regimen during the course of the study unless recommended by their physician.
  • Known Type I or Type II diabetes, including women who previously have had gestational diabetes.
  • Use of antibiotics within 2 weeks of enrollment
  • Metabolic diseases and/or chronic gastrointestinal diseases (IBS, Crohns etc.)
  • Allergy to ingredients included in investigational product, placebo or standardized meal
  • Participants restricted to a vegetarian or vegan diet
  • Intolerance to lactose or gluten
  • Individuals who are averse to venous catheterization or capillary blood sampling
  • Currently active smokers (or using other tobacco products, and e-cigarettes)
  • Unstable medical conditions as determined by QI
  • Participation in other clinical research trials
  • Individuals who are cognitively impaired and/or who are unable to give informed consent
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept Experimental Medical Science, Lund University

Lund, Sweden

Location

MeSH Terms

Conditions

HyperglycemiaMetabolic SyndromeDiabetes Mellitus, Type 2

Interventions

Carbonated WaterAmino AcidsChromium

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesInsulin ResistanceHyperinsulinismDiabetes MellitusEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Mineral WatersWaterHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen CompoundsCarbonated BeveragesBeveragesDiet, Food, and NutritionPhysiological PhenomenaDrinking WaterFood and BeveragesAmino Acids, Peptides, and ProteinsMetals, HeavyElementsTransition ElementsMetals

Study Officials

  • Kristina E Andersson, PhD

    Lund University and Aventure AB

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2018

First Posted

June 11, 2018

Study Start

April 24, 2018

Primary Completion

September 5, 2018

Study Completion

September 5, 2018

Last Updated

September 4, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations